A propos de Laure KAINANE

Posté par Laure KAINANE:

PARTAGER

« La Pataterie » – l’ascension d’une marque suggestive devenue notoire

Les marques évocatrices sont partout et séduisent les déposants autant qu’elles attirent l’attention des consommateurs. Pourtant leur dépôt, de même que leur exploitation, n’est pas sans risque. Juridiquement, la condition sine qua none d’accès à la protection par le droit des marques exige que le signe revendiqué soit distinctif, c’est à dire arbitraire. Or, plus…

Lire la suite
PARTAGER

Middle letters and imitation

On January 9, 2008 the French Trademarks Office ruled positively our opposition and admitted a likelihood of confusion between TRILEPTAL and TRIPLIXAL.The Opposition Division analyzed the resemblance due to the 7 letters in common, same sequence TRI/L/AL same rhythm and close sonorities to conclude that TRIPLIXAL constitutes the imitation of TRILEPTAL. The difference between middle…

Lire la suite
PARTAGER

Focus on the French Health Products Safety Agency

Focus on the French Health Products Safety Agency The French Health Products Safety Agency (Afssaps) was created by the law of 1 July 1998, passed to strengthen existing monitoring and health safety systems, in order to provide an improved response to the increasing diversity and interaction of health safety issues relating to healthcare products. The…

Lire la suite
PARTAGER

Flash On CURON vs./ EURON

  On February 13, 2007, the CFI issued a decision stating that these marks, covering products in class 10, are dissimilar. The Court took the view that the pertinent public was composed of both average consumers and a majority of health professionals. It considered EURO as the dominant element of EURON because the public was…

Lire la suite
PARTAGER

ALREX vs./ ARTEX

  ALREX vs./ ARTEX In the ALREX vs./ ARTEX case, further to the appeal filed against the European Court of First Instance decision, the Advocate General gave his opinion: The acquisition decision is made when the medicine is prescribed by professionals. Thus, when a comparison is made between two pharmaceuticals available only on prescription the…

Lire la suite
PARTAGER

Exclusive Interview of Mrs. Sophie Lalaude in charge of the « Name Work group » (NWG) at the AFSSAPS (French Health Products Safety Agency) – PART I What is the role of the NWG?

 Focus on the French Health Products Safety Agency    The French Health Products Safety Agency (Afssaps) was created by the law of 1 July 1998, passed to strengthen existing monitoring and healthsafety systems, in order to provide an improved response to the increasing diversity and interaction of health safety issues relating to healthcare products. The Afssaps…

Lire la suite